Literature DB >> 25348738

MiR-124 retards bladder cancer growth by directly targeting CDK4.

Ting Zhang1, Jingyao Wang2, Xiaofeng Zhai3, Hongjie Li4, Changying Li1, Jiwu Chang5.   

Abstract

MicroRNAs (miRNAs) are a class of non-coding small RNAs that act as negative regulators of gene expression by binding to the 3'-untranslated region (3'UTR) of target mRNAs. In order to investigate the physiological role of miR-124 in bladder cancer, target genes of miR-124 were predicted by the TargetScan software, and cyclin-dependent kinase (CDK4), which has been implicated as a regulator of cell cycle, was chosen for further study. MiR-124 could significantly repress CDK4 expression by targeting its binding site in the 3'UTR of CDK4 in vitro. In both bladder cancer cell lines and tissues, the expression of miR-124 was significantly down-regulated, while CDK4 expression was up-regulated. Ectopic expression of miR-124 in transplanted HT1197 cells resulted in the retardation of tumor growth in mouse tumor xenografts. And the expression of miR-124 and CDK4 showed an obvious inverse correlation in these xenograft tissues, which was also observed in human bladder cancer tissue samples. Taken together, our results strongly suggest that miR-124 can arrest cell cycle and restrain the growth of bladder cancer by targeting CDK4 directly.
© The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.

Entities:  

Keywords:  CDK4; bladder cancer; miR-124

Mesh:

Substances:

Year:  2014        PMID: 25348738     DOI: 10.1093/abbs/gmu105

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  21 in total

1.  MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.

Authors:  Tongbao Feng; Dongqin Xu; Chao Tu; Wenjing Li; Yongling Ning; Jun Ding; Shizhong Wang; Liudi Yuan; Ning Xu; Keqing Qian; Yong Wang; Chunjian Qi
Journal:  Tumour Biol       Date:  2015-03-03

2.  Hierarchical closeness-based properties reveal cancer survivability and biomarker genes in molecular signaling networks.

Authors:  Tien-Dzung Tran; Yung-Keun Kwon
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 3.  Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Diagn Progn       Date:  2021-07-03

Review 4.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

5.  MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.

Authors:  Jing Lin; Kai Xu; Jun Wei; Amy B Heimberger; Jack A Roth; Lin Ji
Journal:  J Gene Ther       Date:  2016-02-13

Review 6.  The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.

Authors:  Zuhair Hawa; Inamul Haque; Arnab Ghosh; Snigdha Banerjee; LaCoiya Harris; Sushanta K Banerjee
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

Review 7.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

Review 8.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

Review 9.  The role of miRNAs in cutaneous squamous cell carcinoma.

Authors:  Xin Yu; Zheng Li
Journal:  J Cell Mol Med       Date:  2015-10-27       Impact factor: 5.310

10.  miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.

Authors:  Lei Jiang; Tiesu Lin; Chaochao Xu; Sunkuan Hu; Yangyang Pan; Rong Jin
Journal:  J Cell Mol Med       Date:  2015-11-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.